Charles Schwab Portfolio holdings
Charles Schwab Corporation, founded in 1971 by Charles R. Schwab and headquartered in Westlake, Texas, is a leading financial services firm that revolutionized retail investing by offering low-cost brokerage services. Initially disrupting the industry with discount commissions, it has grown into a powerhouse providing a wide array of services, including trading platforms, robo-advisors, retirement accounts, and banking products, managing hundreds of billions in client assets. Known for its user-friendly technology and customer-centric approach, Schwab caters to individual investors, financial advisors, and institutions, notably expanding through its 2020 acquisition of TD Ameritrade. With a mission to democratize investing, Charles Schwab remains a dominant force in the shift toward accessible, self-directed wealth management.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares MBS ETF
MBB
|
+$1.13B |
| 2 |
Vanguard FTSE Developed Markets ETF
VEA
|
+$821M |
| 3 |
State Street SPDR Portfolio Intermediate Term Corporate Bond ETF
SPIB
|
+$770M |
| 4 |
ExxonMobil
XOM
|
+$605M |
| 5 |
Johnson & Johnson
JNJ
|
+$599M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
LPT
Liberty Property Trust
LPT
|
+$139M |
| 2 |
WCG
Wellcare Health Plans, Inc.
WCG
|
+$75.9M |
| 3 |
ZAYO
Zayo Group Holdings, Inc.
ZAYO
|
+$48.7M |
| 4 |
Darden Restaurants
DRI
|
+$41.9M |
| 5 |
MDCO
Medicines Co
MDCO
|
+$39M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.64% |
| 2 | Healthcare | 13.41% |
| 3 | Financials | 11.59% |
| 4 | Industrials | 9.19% |
| 5 | Consumer Discretionary | 8.91% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
TLRA
2601
DELISTED
Telaria, Inc.
TLRA
| $677K | ﹤0.01% |
112,751
+10,876
| +11% | +$108K |
|
2602
Capital City Bank Group
CCBG
$890M
| $676K | ﹤0.01% |
33,561
-885
| -3% | -$23.2K |
|
2603
Vanguard International Dividend Appreciation ETF
VIGI
$9.3B
| $675K | ﹤0.01% |
+11,571
| New | +$782K |
|
2604
Castle Biosciences
CSTL
$979M
| $674K | ﹤0.01% |
22,602
+12,267
| +119% | +$370K |
|
|
MORF
2605
DELISTED
Morphic Holding, Inc. Common Stock
MORF
| $673K | ﹤0.01% |
45,821
+12,762
| +39% | +$214K |
|
2606
Universal Logistics Holdings
ULH
$529M
| $671K | ﹤0.01% |
51,154
+715
| +1% | +$11.8K |
|
|
APLT
2607
DELISTED
Applied Therapeutics
APLT
| $670K | ﹤0.01% |
20,486
+6,845
| +50% | +$277K |
|
2608
Liquidity Services
LQDT
$1.31B
| $670K | ﹤0.01% |
172,631
+5,983
| +4% | +$28.5K |
|
2609
Digi International
DGII
$3.1B
| $666K | ﹤0.01% |
69,777
+890
| +1% | +$12.3K |
|
2610
UFP Technologies
UFPT
$2.43B
| $665K | ﹤0.01% |
17,449
-35
| -0.2% | -$1.61K |
|
|
FSB
2611
DELISTED
Franklin Financial Network, Inc.
FSB
| $660K | ﹤0.01% |
32,320
+191
| +0.6% | +$6.08K |
|
2612
Bloom Energy
BE
$64.6B
| $659K | ﹤0.01% |
125,903
+15
| +0% | +$127 |
|
2613
Metropolitan Bank Holding Corp
MCB
$1.15B
| $659K | ﹤0.01% |
24,465
+6,834
| +39% | +$285K |
|
2614
Arcutis Biotherapeutics
ARQT
$3.18B
| $657K | ﹤0.01% |
+22,021
| New | +$592K |
|
2615
Lindblad Expeditions
LIND
$2.22B
| $657K | ﹤0.01% |
157,401
-38,260
| -20% | -$491K |
|
2616
Precision BioSciences
DTIL
$207M
| $655K | ﹤0.01% |
3,619
+11
| +0.3% | +$2.88K |
|
2617
Revolution Medicines
RVMD
$44B
| $655K | ﹤0.01% |
+29,881
| New | +$827K |
|
2618
ACNB Corp
ACNB
$655M
| $651K | ﹤0.01% |
21,670
+4,977
| +30% | +$160K |
|
2619
Bar Harbor Bankshares
BHB
$666M
| $651K | ﹤0.01% |
37,663
-1,202
| -3% | -$25.6K |
|
|
GSKY
2620
DELISTED
GreenSky, Inc. Class A Common Stock
GSKY
| $650K | ﹤0.01% |
169,989
+25,304
| +17% | +$188K |
|
2621
Bristow Group
VTOL
$1.36B
| $649K | ﹤0.01% |
60,852
+1,002
| +2% | +$17.8K |
|
2622
Transmedics
TMDX
$2.91B
| $647K | ﹤0.01% |
53,494
+536
| +1% | +$8.98K |
|
2623
Daily Journal
DJCO
$778M
| $645K | ﹤0.01% |
2,821
+14
| +0.5% | +$3.68K |
|
2624
HCI Group
HCI
$2.41B
| $645K | ﹤0.01% |
16,016
| – | – |
|
|
STSA
2625
DELISTED
Satsuma Pharmaceuticals, Inc. Common Stock
STSA
| $643K | ﹤0.01% |
29,875
-3,640
| -11% | -$82.6K |
|
Similar funds
Charles Schwab's Q1 2020 Portfolio in Review
As of Q1 2020, Charles Schwab held 3,284 positions worth $170B, down 8.5% from $186B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Charles Schwab deployed $31.1B of net new capital in Q1 2020, opening 103 new positions and adding to 2,418 existing holdings. Its largest new stake was iShares MBS ETF: 10,382,066 shares worth $1.15B.
By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 18% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Darden Restaurants, an estimated $41.9M trimmed.
- Charles Schwab's largest Q1 2020 buy was iShares MBS ETF: 10,382,066 shares worth $1.15B.
- Charles Schwab added most to ExxonMobil in Q1 2020, an estimated $605M increase.
- Charles Schwab's biggest Q1 2020 reduction was Darden Restaurants, cutting an estimated $41.9M.
- Charles Schwab fully exited Liberty Property Trust in Q1 2020, selling an estimated $139M.
- Charles Schwab's ten largest holdings make up 17% of its $170B portfolio in Q1 2020.
- Charles Schwab opened 103 new positions and closed 50 in Q1 2020.
- Charles Schwab's portfolio value fell 8.5% quarter-over-quarter to $170B.
Based on Charles Schwab's 13F filing for Q1 2020, filed 15 May 2020.